Articles Archives - Page 122 of 714

TuesdayNov 21, 2023 9:00 am

Sekur Private Data Ltd. (CSE: SKUR) (OTCQB: SWISF) (FRA: GTD0) Offering SekurMessenger, its Encrypted Messenger App, Amid SEC FINRA Violations Crackdown

Sekur, a cybersecurity and internet privacy provider of Swiss-hosted solutions for secure communications and secure data management, is pushing its SekurMessenger amid SEC crackdowns on Wall Street The app provides end-to-end encryption, proprietary VirtualVaults, and HelixTech that ensure conversations are secure while also maintaining privacy It allows companies on Wall Street to meet the FINRA communication compliance requirements while giving them the overall peace of mind that comes with guaranteed security and encryption With this offering, Sekur looks to carve out a significant market share while also asserting itself as a leader in its segment Sekur Private Data (CSE: SKUR)…

MondayNov 20, 2023 11:15 am

SuperCom Ltd. (NASDAQ: SPCB) Announces Extended Collaboration with Romanian Government Following Third $3.4 Million Order

SuperCom, a global leading provider of traditional and digital identity solutions, just announced its latest order from the Romanian government to the tune of $3.4 million SuperCom will help Romania’s Ministry of Interior to bolster its EM project, based on its PureSecurity Suite, covering domestic violence monitoring, GPS tracking of offenders, as well as home detection monitoring Deliveries are set to be met by the end of Q4 2023, and SuperCom’s management is optimistic that the order will boost the company’s overall value proposition and lead to many more orders down the line SuperCom (NASDAQ: SPCB), a leading global provider…

MondayNov 20, 2023 10:30 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Looking to Generate Sizable License Revenue from IP Growth, Expanding Patent Suite

Lexaria, a global innovator in drug delivery platforms, has, since 2014, continuously worked on its patented DehydraTECH(TM) drug delivery technology The technology has demonstrated overall effectiveness in enhanced delivery of fat-soluble molecules through the human gastrointestinal system, as affirmed by clinical testing This overall effectiveness and push for its development has earned Lexaria 37 granted patents globally, with many patents pending The company is constantly enhancing its patent portfolio, since granted patents can support an increase in licensing revenue Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, is eyeing growth in license revenue from its intellectual property…

MondayNov 20, 2023 9:45 am

Turbo Energy S.A. (NASDAQ: TURB) Is ‘One to Watch’

Turbo Energy in September 2023 announced its successful debut on the Nasdaq stock exchange The company operates as a subsidiary of Umbrella Solar Investment S.A. Turbo Energy’s total revenue for the year ended December 31, 2022, increased by 82% year-over-year to €31,148,676 (approximately $33,321,219) In October 2023, the company was awarded a software patent in Spain related to its flagship Sunbox product Turbo Energy (NASDAQ: TURB) designs, develops and distributes equipment for the generation, management and storage of photovoltaic energy in Spain, Europe and internationally. Turbo Energy’s products include lithium-ion batteries and inverters. Additionally, the company recently launched its flagship…

MondayNov 20, 2023 9:00 am

SenesTech Inc. (NASDAQ: SNES) Issues Q3 Report Amid Rollout of New Soft Bait Rodent Birth Control Formulation

SenesTech Inc., a visionary leader in fertility control to manage animal pest populations, has developed products that show success in limiting rat populations using unique non-lethal fertility reduction products Rodents are often associated with carrying diseases that can affect humans, and SenesTech’s non-lethal population-reducing technology targets this major problem in a uniquely humane, environmentally conscious, yet effective way The Arizona-based company has developed two primary products — its liquid ContraPest(R) brand, and the recently introduced Evolve(TM) Soft Bait formulation, soft bait being favored by rodent control professionals The company anticipates using their technology to develop similar pest-control products for other…

FridayNov 17, 2023 9:45 am

D-Wave Quantum Inc. (NYSE: QBTS) Announces European Office, Signs Two-Year Contract Extension with QuantumBasel

D-Wave and QuantumBasel announced a two-year extension to the strategic agreement between the companies to accelerate quantum and quantum-hybrid application development in Europe D-Wave will open a European office on the QuantumBasel campus to establish an onsite presence supporting the companies’ joint efforts to fast-track the region’s commercialization of quantum computing D-Wave’s European customers include QuantumBasel, BBVA, Koç Holding, Satispay, Poznan Superconducting and Network Center, and Cineca D-Wave Quantum (NYSE: QBTS), a leader in quantum computing systems, software, and services and the world’s first commercial supplier of quantum computers, and QuantumBasel, Switzerland’s quantum innovation hub, recently announced a two-year extension…

FridayNov 17, 2023 9:00 am

GolfLync Inc. Influencers and Social Platform Expansion

GolfLync, a leading social networking hub for golf lovers, is revolutionizing the online golfing world. Recently, influencers from various platforms have been flocking to GolfLync, bringing along their followers. This trend has led GolfLync to introduce an array of features aimed at enabling these influencers to broaden their reach and grow their brand. This integration not only enhances the visibility of influencers but also provides them with tools to manage and rotate posts across the feeds.In an effort to bolster the credibility and authenticity of its influencer community, GolfLync has implemented a new verification process. Influencers can now apply for…

ThursdayNov 16, 2023 11:15 am

Diamond Lake Minerals Inc. (DLMI) Building Value for Investors with Focus on STO Frontier, Other Digital Assets

Diamond Lake Minerals is multi-strategy operating company focused on building, acquiring and developing companies within a wide variety of industries DLMI’s strategy involves bridging generations of investors with accessible digital investment technology in sectors ranging from music and entertainment to real estate, healthcare and digital tokens Security token-centered ecosystems are gaining traction around the world, providing digital alternatives to traditional investments such as stocks or bonds — digital investments that may nonetheless deliver rights to assets that have real value DLMI is conscientious about the need to comply with SEC regulations and provide transparency to its shareholders, drawing on the…

ThursdayNov 16, 2023 10:30 am

Freight Technologies Inc. (NASDAQ: FRGT) CEO Underscores Commitment to Continued Growth in Letter to Shareholders

Fr8Tech CEO recently wrote a letter to shareholders summarizing the company’s financial milestones and operational successes CEO Javier Selgas discussed the company’s robust revenue growth in Q2 2023 as well as the 93% year-over-year increase in its gross margins during the first half of the year The company’s commitment to innovation has led to the launch of an LTL offering and the establishment of an AI department Fr8Tech has successfully expanded into new markets, completed a number of strategic integrations with third-party solutions, and grown its customer base Freight Technologies (NASDAQ: FRGT) (“Fr8Tech”), a technology company whose lead product is…

ThursdayNov 16, 2023 9:45 am

Clene Inc. (NASDAQ: CLNN) Reports Q3 2023 Financial Results, Recent Operating Highlights for Its ALS Clinical Program

Clene recently released its financial results for the third quarter ended September 30, 2023, and provided recent operating highlights for its ALS clinical program The ALS clinical program includes two independent studies evaluating the safety and efficacy of the company’s lead investigational product CNM-Au8(R) The 24-month long-term data cut from the open-label extension of the RESCUE-ALS study showed a significant median survival benefit of 19.3 months, a significant 52% decreased risk of ALS clinical worsening events, and a 75% decreased risk of long-term all-cause mortality Clene also summarized long-term follow-up data from the HEALEY ALS platform trial, which demonstrated significantly…

Site Search

Company Search

Category: Articles